Related Topics:
Facility ID: 30603NRMCN1440O
Facility Name and Address: JANSSEN PHARMACEUTICALS INC. 1440 OLYMPIC DR ATHENS, GA 30601 Parent Company: JOHNSON & JOHNSON INC Industry: Medicinal and Botanical Manufacturing (325411) Chemical: Ammonia Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0007664417
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2022 |
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens.
|
Barriers to P2: B5 - Specific regulatory/permit burdens. - FDA Drug Master File |
|
2020 |
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens.
|
Barriers to P2: B5 - Specific regulatory/permit burdens. - Use quantity determined by FDA Drug Master Filing. |
|
2018 |
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens.
|
Barriers to P2: B5 - Specific regulatory/permit burdens. - FDA covered process |
|
2017 |
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens.
|
Barriers to P2: B5 - Specific regulatory/permit burdens. - FDA regulated process - quantities used in production are specified in approved Drug Master File |
|
2016 |
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens.
|
Barriers to P2: B5 - Specific regulatory/permit burdens. - Quantities used in production are approved by FDA in the product Drug Master File |